BusinessHorizon Pharma plc Presents New Data at 2017 ACR/ARHP Annual Meeting, Advances Clinical Understanding of KRYSTEXXA® (pegloticase injection) in Adults with Uncontrolled GoutBy Nasdaq OMXNov 6, 2017, 5:00 PM UTC
